Matches in Nanopublications for { ?s ?p "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP940731.RA3yXpSLnHguODVwCvzu3m2M5sbeC6shLTR_S3j9dLGmc130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940731.RA3yXpSLnHguODVwCvzu3m2M5sbeC6shLTR_S3j9dLGmc130_provenance.
- NP905881.RA_MPqFZ_ocvctuHyed3ZzePz0swT7yegpOqhIT_fxqZE130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905881.RA_MPqFZ_ocvctuHyed3ZzePz0swT7yegpOqhIT_fxqZE130_provenance.
- NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905884.RASsUmsxZT8XbwhN3sb4K7U0Ibg2TJqB4daIfMWnDIOBA130_provenance.
- assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP869838.RAI2ErnO_-DBLYbtIvQoM4C1IGOlXAurVRNgDSTfK0BA8130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869838.RAI2ErnO_-DBLYbtIvQoM4C1IGOlXAurVRNgDSTfK0BA8130_provenance.
- assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP860258.RAoZxOlRbLNH3lpSVakXH3oMypVsgZmBLrqqANRSIIsaw130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860258.RAoZxOlRbLNH3lpSVakXH3oMypVsgZmBLrqqANRSIIsaw130_provenance.
- NP905880.RAvFGRslSBebkilp7rK7sLyijIA3o0H0Z8m23rOJTf1jg130_assertion description "[In the present study, we examined 811 consecutive cases of B-cell lymphoproliferative disorders (B-LPDs), and demonstrated CD160 expression in 98% (590 of 600) of chronic lymphocytic leukemia (CLL) cases, 100% (32 of 32) of hairy cell leukemia (HCL) cases, 15% (5 of 34) of mantle cell lymphoma (MCL) in the leukemic phase, and 16% (23 of 145) of other B-LPD cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905880.RAvFGRslSBebkilp7rK7sLyijIA3o0H0Z8m23rOJTf1jg130_provenance.